Aktocyte Tablets

  • 15th December, 2023
  • It will enhance the quality of life of cancer patients undergoing radiotherapy.
  • It is developed by Department of Atomic Energy and IDRS Labs Pvt. Ltd. Made by scientists.
  • It has received approval from FSSAI.
  • Its remarkable results have been seen in the treatment of pelvic cancer patients.
  • After this the need for surgical removal of the bladder was eliminated.
  • It is expected to hit the market in January 2024.
CONNECT WITH US!

X
Classroom Courses Details Online Courses Details Pendrive Courses Details PT Test Series 2021 Details